Ghanizadeh-Vesali, Samad <br/><br/>
Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.  [electronic resource] 

 -  Annals of hematology  Jun 2016 
 - 1031-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-016-2670-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aurora Kinase B--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Organophosphates--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>Treatment Outcome